PLANETS
4.2.2020 03:02:07 CET | Business Wire | Press release
teamLab Planets TOKYO is a museum in Toyosu, Tokyo where you walk through water and can immerse yourself in massive artworks barefoot. In the first year since teamLab Planets TOKYO opened in July of 2018, there have been more than 1.25 million visitors from 106 countries and regions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200203005275/en/
At teamLab Planets TOKYO, two artworks in the museum will be transformed by cherry blossoms for a limited time from March 1 to April 30, 2020.
Also, with the opening of the Toyosu Fish Market and Edomae Jokamachi nearby, you can enjoy food made using fresh ingredients, collect Japanese Culture souvenirs, and enjoy local shopping.
- Cherry Blossoms Transform Two Artworks
In the work Floating in the Falling Universe of Flowers , flowers bloom and change with every passing minute, creating a universe of life that spreads across the space. For a limited time only, cherry blossoms fall in the art space.
In another artwork, Drawing on the Water Surface Created by the Dance of Koi and People - Infinity , visitors walk barefoot through real water, as koi swim across the infinite water's surface. When the koi collide with people, they bloom into cherry blossoms. The flowers that bloom change in real time according to the seasonal changes of the year.
Check the teamLab Planets website for more details: https://planets.teamlab.art/
teamLab Planets highlight video: https://youtu.be/cqiv_FV8iT4
- Become Bodily Immersed in a Massive Art Space
teamLab Planets is a museum where you walk through water. It consists of 4 vast exhibition spaces with 7 distinct artworks. The artworks are based on art collective teamLab’s concept of “Body Immersive.”
By immersing the entire body with other people in these massive “Body Immersive” artworks, the boundary between the body and the artwork dissolves, the boundaries between the self, others, and the world become something continuous, and we explore a new relationship without boundaries between ourselves and the world.
Visitors enter the museum barefoot, and become completely immersed with other visitors in the vast artwork spaces.
- Artworks Transformed by Cherry Blossoms
Floating in the Falling Universe of Flowers
teamLab, 2016-2018, Interactive Digital Installation, Endless, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/fitfuof/
Video: https://youtu.be/FzJ5svgIueQ
A seasonal year of flowers bloom and change with time, life spreads out into the universe.
Lie down or sit still in the space and eventually your body floats and you dissolve into the artwork world.
The artwork is rendered in real time by a computer. I is neither prerecorded nor on loop. Interaction between the viewer and the installation causes continuous change in the artwork.
Flowers grow, bud, bloom, and in time, the petals fall, and the flowers wither and die. The cycle of birth and death continues for perpetuity.
The universe at this moment in time can never be seen again.
Drawing on the Water Surface Created by the Dance of Koi and People - Infinity
teamLab, 2016-2018, Interactive Digital Installation, Endless, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/koi_and_people/
Video: https://youtu.be/SsRNptTOniw
Koi swim on the surface of water that stretches out into infinity. People can walk into the water.
The movement of the koi is influenced by the presence of people in the water and also other koi. When the fish collide with people they turn into flowers and scatter. Throughout a year, the flowers that bloom will change along with the seasons.
The trajectory of the koi is determined by the presence of people and these trajectories trace lines on the surface of the water.
The work is rendered in real time by a computer program. It is neither prerecorded nor on loop. The interaction between the viewer and the installation causes continuous change in the artwork. Previous visual states can never be replicated, and will never reoccur.
- Museum overview
teamLab Planets TOKYO
Address: teamLab Planets TOKYO, Toyosu 6-1-16, Koto-ku, Tokyo
Hours: Monday - Thursday 10:00 - 19:00
Friday 10:00 - 21:00
Saturday and the day before holidays 9:00 - 21:00
Sunday and Holidays 9:00 - 19:00
* Last entry 30 minutes before closing.
* Special hours Friday, March 20 - Saturday, April 4: 9:00 - 21:00
* Special hours Sunday, April 5: 9:00 - 19:00
Closed:
Thursday, February 13, 2020
Thursday, March 12, 2020
Monday, April 6, 2020
Tuesday, April 14, 2020
Wednesday, April 15,2020
Admission:
Adults (18 years and older) JPY 3,200
University students / Specialized students JPY 2,500
Junior high school students / High school students JPY 2,000
Children (Ages 4-12) JPY 800
Seniors (65 years and older) JPY 2,400
Disability discount JPY 1,600
teamLab Planets website: https://planets.teamlab.art/
teamLab Planets TOKYO Ticket Store: https://teamlabplanets.dmm.com
* Prices and opening hours are subject to change. Please check the official website before visiting.
- Social Networking Sites:
Instagram: https://www.instagram.com/teamlab.planets/
Facebook: https://www.facebook.com/TL.Planets/
Twitter: https://twitter.com/teamLabPlanets
#teamLabPlanets
- Jointly Managed Food Stand
Everything is in your hand
- Hours -
Monday - Thursday 10:00 - 18:00
Friday 10:00 - 20:00
Saturday and the day before holidays 10:00 - 20:00
Sunday and Holidays 10:00 - 18:00
- Closed -
Same as teamLab Planets
* Establishment may be closed in cases of extreme weather.
Check here for more information: https://planets.teamlab.art/tokyo/foodstand
PLANETS Co., Ltd.
The managing entity for facilities operations at teamLab Planets TOKYO and the associated restaurants.
Address: Tokyo Nihonbashi Tower 26F, 2-7-1 Nihonbashi, Chuo-ku, Tokyo
Representative: Takumi Nomoto
teamLab
teamLab (f. 2001) is an international art collective, an interdisciplinary group of various specialists such as artists, programmers, engineers, CG animators, mathematicians and architects whose collaborative practice seeks to navigate the confluence of art, science, technology, and the natural world.
teamLab aims to explore the relationship between the self and the world and new perceptions through art. In order to understand the world around them, people separate it into independent entities with perceived boundaries between them. teamLab seeks to transcend these boundaries in our perception of the world, of the relationship between the self and the world, and of the continuity of time. Everything exists in a long, fragile yet miraculous, borderless continuity of life.
teamLab has been the subject of numerous exhibitions at venues worldwide, including New York, London, Paris, Singapore, Silicon Valley, Beijing, Taipei, and Melbourne among others. The permanent museums teamLab Borderless opened in Odaiba, Tokyo in June 2018, and teamLab Borderless Shanghai in Huangpu District, Shanghai on November 5, 2019. The massive body immersive space teamLab Planets in Toyosu, Tokyo is on view until Fall 2020. The latest permanent museum teamLab SuperNature in Macao to launch in March, 2020.
teamLab’s works are in the permanent collection of the Art Gallery of New South Wales, Sydney; Art Gallery of South Australia, Adelaide; Asian Art Museum, San Francisco; Asia Society Museum, New York; Borusan Contemporary Art Collection, Istanbul; National Gallery of Victoria, Melbourne; and Amos Rex, Helsinki.
teamLab is represented by Pace Gallery .
teamLab: https://www.teamlab.art/
Instagram: https://instagram.com/teamlab/
facebook: https://www.facebook.com/teamLab.inc
twitter: https://twitter.com/teamLab_net
YouTube: https://www.youtube.com/c/teamLabART
View source version on businesswire.com: https://www.businesswire.com/news/home/20200203005275/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 08:10:00 CEST | Press release
AI-native operations model enables enterprises to move from reactive service delivery to intelligent, outcome-driven managed services LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across sys
Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press release
Autonomous launch, recovery, and recharge from military vehicles and fixed installations; Three-drone rotation provides persistent surveillance and real-time targeting data in contested environments Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integrati
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom